{"id":"NCT01165138","sponsor":"GlaxoSmithKline","briefTitle":"Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics","officialTitle":"HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2010-08-20","primaryCompletion":"2011-10-01","completion":"2011-10-19","firstPosted":"2010-07-19","resultsPosted":"2013-07-30","lastUpdate":"2018-02-14"},"enrollment":612,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"TREATMENT"},"conditions":["Asthma"],"interventions":[{"type":"DRUG","name":"Fluticasone furoate/Vilanterol Inhalation Powder","otherNames":[]},{"type":"DRUG","name":"Fluticasone Furoate Inhalation Powder","otherNames":[]},{"type":"DRUG","name":"Placebo Inhaltion Powder","otherNames":[]}],"arms":[{"label":"Fluticasone furoate/Vilanterol (GW642444)","type":"EXPERIMENTAL"},{"label":"Fluticasone Furoate","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of the study is to compare the efficacy and safety of fluticasone furoate/vilanterol (GW642444) inhalation powder and fluticasone furoate inhalation powder both administered once daily in adolescent and adult subjects 12 years of age and older with persistent bronchial asthma over a 12 week treatment period.","primaryOutcome":{"measure":"Mean Change From Baseline in Clinic Visit Trough (Pre-bronchodilator and Pre-dose) Forced Expiratory Volume in One Second (FEV1) at Week 12","timeFrame":"Baseline and Week 12","effectByArm":[{"arm":"Placebo","deltaMin":0.196,"sd":0.031},{"arm":"FF 100 µg OD","deltaMin":0.332,"sd":0.0302},{"arm":"FF/VI 100/25 µg OD","deltaMin":0.368,"sd":0.0304}],"pValues":[{"comp":"OG000 vs OG001","p":"0.002"},{"comp":"OG000 vs OG002","p":"<0.001"},{"comp":"OG001 vs OG002","p":"0.405"}]},"eligibility":{"minAge":"12 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":8},"locations":{"siteCount":70,"countries":["United States","Germany","Japan","Poland","Romania","Ukraine"]},"refs":{"pmids":["27881132","26704701","25213048","24966061","24314123"],"seeAlso":["https://www.clinicalstudydatarequest.com"]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":203},"commonTop":["Nasopharyngitis","Headache"]}}